S3 CYCLIC RPM CONTROL
K971520 · Stoeckert Instrumente · DWB · Sep 10, 1997 · Cardiovascular
Device Facts
| Record ID | K971520 |
| Device Name | S3 CYCLIC RPM CONTROL |
| Applicant | Stoeckert Instrumente |
| Product Code | DWB · Cardiovascular |
| Decision Date | Sep 10, 1997 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 870.4370 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The Stöckert S3 Cyclic RPM Control Module is an accessory to the S3 Cardiopulmonary Bypass System Console which allows for the cyclic rpm control of an S3 pump.
Device Story
The Stöckert S3 Cyclic RPM Control Module is an accessory for the S3 Cardiopulmonary Bypass System. It enables roller or double head pumps to operate in a pulsed flow mode. The device processes control inputs to modulate pump speed cyclically. It is used in clinical settings (e.g., OR) by perfusionists or clinicians to manage blood flow during bypass. The output is a controlled, pulsed pump rotation, which aims to provide physiological benefits of pulsatile flow during extracorporeal circulation. The module features updated software controls and user interface panels compared to the predicate.
Clinical Evidence
No clinical data. Evidence consists of bench testing, including electrical testing, functional acceptance testing, and software verification and validation testing. The device conforms to IEC 601 and IEC 62a standards.
Technological Characteristics
Accessory module for cardiopulmonary bypass pump control. Features updated software and control/display panels. Conforms to IEC 601 and IEC 62a. Manufacturing facility is ISO 9001 certified.
Indications for Use
Indicated for use as an accessory to the S3 Cardiopulmonary Bypass System to enable cyclic (pulsed) flow mode for roller or double head pumps during cardiopulmonary bypass procedures.
Regulatory Classification
Identification
A roller-type cardiopulmonary bypass blood pump is a device that uses a revolving roller mechanism to pump the blood through the cardiopulmonary bypass circuit during bypass surgery.
Predicate Devices
- Stöckert-Shiley CAPS PFC 100 S Control unit (K883456)
Related Devices
- K042374 — STOCKERT SCP RHYTHM · Stockert Instrumente GmbH · Sep 23, 2004
- K091008 — STOCKERT CENTRIFUGAL PUMP PLUS SYSTEM (SCP PLUS), MODELS 60-00-10, 60-00-55 · Sorin Group Deutschland GmbH · Jul 15, 2009
- K972321 — S3 MAST PUMP · Stoeckert Instrumente · Feb 27, 1998
- K962320 — S3 CARDIOPLEGIA CONTROL · Stoeckert Instrumente · Jan 10, 1997
- K103468 — STOCKERT CENTRIFUGAL PUMP (SCP PLUS) (COMPLETE) OR (FOR S5/C5 SYSTEMS) · Sorin Group Deutschland GmbH · Jan 20, 2011
Submission Summary (Full Text)
{0}------------------------------------------------
KII>CO
SEP 1 0 1997
## Appendix F
# 510(k) Summary
{1}------------------------------------------------
### 510(k) Summary
### STÖCKERT S3 PERFUSION SYSTEM CYCLIC RPM CONTROL MODULE
| 1. | Date Prepared: | April 24, 1997 |
|----|------------------------|------------------------------------------------------------------------------|
| 2. | Submitter: | Stöckert Instrumente, GmbH<br>Lilienthalallee 5-7<br>D-80939 Munich, Germany |
| 3. | Contact: | Helmut Höfl<br>011-49-89-32301-0 |
| 4. | Device Name: | Stöckert S3 Perfusion System<br>Cyclic RPM Control Module |
| 5. | Device Classification: | Class II, 21 CFR 870.4370 |
#### Device Description and Comparison to Predicate Products: 6.
The Stöckert S3 Cyclic RPM Control Module is an accessory module to the Stöckert S3 (cardiopulmonary bypass) Perfusion System, and is intended to allow the roller pump or double head pump to operate in the pulsed flow mode. The predicate and predecessor device to the S3 Cyclic RPM Control Module is the Stöckert-Shiley CAPS PFC 100 S Control unit (K883456). Similar devices have been used for many years for this same intended purpose. The new S3 Cyclic RPM Control Module is a simple upgrade of the technological aspects of the predicate device, e.g., the software controls and have been updated and the control and display panels have been updated for user convenience in operating the system.
{2}------------------------------------------------
Information supplied in this premarket notification to support a determination of substantial equivalence for this device included descriptive information about the design, materials, and intended use of the device, as well as extensive testing results characterizing device performance. Testing included electrical testing, functional acceptance testing, and software verification and validation testing. The Stöckert S3 Perfusion System, including the Cyclic RPM Control Module, conforms with the applicable requirements of IEC 601, and IEC 62a. The manufacturing facility is ISO 9001 certified, and the device holds the CE mark in the European Union.
Page F-2
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The words "HUMAN SERVICES • USA" and "DEPARTMENT" are arranged in a circular fashion around the eagle symbol. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856
Stöckert Instrumente GmbH SEP 1 0 1997 c/o Ms. Rosina Robinson Staff Consultant Medical Device Consultants, Inc. 49 Plain Street North Attleboro, Massachusetts 02760
Re: K971520 Stöckert S3 Cyclic RPM Control Module Requlatory Class: II (Two) Product Code: 74 DWB Dated: August 6, 1997 Received: August 8, 1997
Dear Ms. Robinson:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labelinq, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act
{4}------------------------------------------------
#### Page 2 - Ms. Rosina Robinson
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diaqnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html."
Sincerely yours,
Thomas J. Callahon
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
k 97 1520 510(k) Number (if known): _
Device Name: Stöckert S3 Bypass System Cyclic RPM Control Module_
Indications For Use:
The Stöckert S3 Cyclic RPM Control Module is an accessory to the S3 Cardiopulmonary Bypass System Console which allows for the cyclicapm control offan;S3:pump.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Bette R. Semperele
Division Sign-Off) Wision of Cardiovascular, Respiratory, and Neurological Devices
510(k) Number
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
Stöckert S3 Cyclic RPM Control Module 510(k)
4/24/97
Page vi